New synthetic surfactants--basic science.
The hydrophobic surfactant proteins, SP-B and SP-C, promote adsorption of surface-active lipids to the air-liquid interface of the alveoli and are essential for alveolar stability and gas exchange. Synthetic surfactant preparations must contain at least one of these hydrophobic proteins, or analogs thereof, to have optimal effects when administered into the airways of patients with lung diseases. However, development of clinically active artificial surfactants has turned out to be more complicated than initially anticipated since the native hydrophobic proteins are structurally complex or unstable in pure form. The proteins have been replaced by different analogs which have the right conformation without forming oligomers. Increased understanding of the surfactant proteins will hopefully lead to development of effective synthetic surfactants which can be produced in large quantities for treatment of a wide range of respiratory disorders. Furthermore, the lipid composition seems to be important, as well as a high lipid concentration in the suspension. For successful treatment of many respiratory diseases, it is also desirable that the synthetic surfactant resists inactivation by plasma components leaking into the alveoli.
Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden. tore.curstedt@karolinska.se
Tore
T
Curstedt
Jan
J
Johansson
D000818:Animals; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D037701:Pulmonary Surfactant-Associated Protein B / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D037721:Pulmonary Surfactant-Associated Protein C / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy
D037701:Pulmonary Surfactant-Associated Protein B; D037721:Pulmonary Surfactant-Associated Protein C